Your Hair Is Thinning, Your Thyroid Looks Normal. Here's Why.

TPO is the primary enzyme your thyroid gland uses to synthesize thyroid hormones (T4 and T3). It catalyzes the critical steps of iodine incorporation into thyroid hormone precursors. Without functional TPO, your thyroid literally cannot produce hormone at all.

The TPO variant (rs11675434 and related SNPs) occurs in roughly 20-30% of people. Carriers often develop Hashimoto’s thyroiditis, an autoimmune attack on the thyroid that destroys TPO-producing cells, leading to progressive hypothyroidism and severe hair loss. Even if you don’t have full Hashimoto’s, a TPO variant reduces the efficiency of thyroid hormone synthesis, leaving you with chronically insufficient hormone production even if your TSH is ‘normal’ because your pituitary is working overtime to compensate.

With a TPO variant, you experience persistent low-grade hypothyroidism: hair falls out because follicles don’t get enough T3, your metabolism slows despite eating the same amount, you feel cold constantly, and you fatigue easily even after rest. Standard thyroid medication often doesn’t fully resolve symptoms because the underlying problem is not enough TSH stimulation but genetic inefficiency in hormone production.

TSHR is the receptor on thyroid cells that receives the signal from pituitary TSH to produce and release thyroid hormone. Think of it as the mailbox where your pituitary leaves instructions. If the receptor is less sensitive, your thyroid doesn’t get the signal as clearly, so it produces less hormone until TSH climbs high enough to compensate.

TSHR variants (various SNPs) affect roughly 10-20% of people and alter the sensitivity of this receptor. Carriers often have higher TSH levels relative to their free T4 and T3, meaning their body is shouting to the thyroid but the thyroid isn’t responding efficiently. This is associated with Graves’ disease susceptibility and unpredictable TSH range shifts across your lifespan. You might have a TSH of 2.5 one year and 4.2 the next without obvious lifestyle changes.

With a TSHR variant, your hair may thin intermittently, your energy crashes when TSH drifts up, and thyroid medication dosing can feel unpredictable. You might need more levothyroxine than standard formulas suggest. Your TSH might remain elevated even on medication because your cells simply don’t respond to TSH as strongly as others do.

DIO2 is the enzyme responsible for converting T4 (the storage form of thyroid hormone) into T3 (the active form your cells actually use). Most of your T4 is converted by this enzyme in peripheral tissues like muscle, liver, and brain. Without sufficient DIO2 activity, you have normal T4 and even normal TSH but tissue-level hypothyroidism because your cells can’t access the active hormone.

The DIO2 Thr92Ala variant (rs225014) occurs in roughly 12-15% of people homozygous for the Ala allele. Carriers have significantly impaired T4-to-T3 conversion, meaning they accumulate T4 but cannot activate it efficiently in tissues. TSH stays normal because the pituitary senses enough T4; but your hair, metabolism, and brain experience profound T3 deficiency. This is the variant most associated with patients saying, ‘I feel so much better on T3 supplements than on levothyroxine alone,’ because they’re bypassing the broken DIO2 step entirely.

With a DIO2 variant, you experience persistent tissue hypothyroidism despite normal or low-normal TSH and adequate free T4. Your hair sheds, you’re exhausted, you feel cold, metabolism is sluggish, and mood can drop. Standard levothyroxine monotherapy rarely fully resolves symptoms. Many people with this variant need either T3 supplementation or a combination T4/T3 approach.

MTHFR catalyzes a critical step in the methylation cycle, converting folate into its active form so your body can maintain proper methylation (the biochemical process that controls gene expression, detoxification, and hormone metabolism). Thyroid hormone metabolism, thyroid antibody regulation, and the function of selenium-dependent thyroid peroxidase all depend on adequate methylation capacity.

The MTHFR C677T variant occurs in roughly 40% of people with European ancestry and reduces enzyme efficiency by 35-40%. Carriers often have elevated thyroid antibodies, impaired thyroid hormone metabolism, and reduced function of selenium-dependent enzymes that protect the thyroid from autoimmune attack. You might have normal TSH and T4 but climbing anti-TPO or anti-thyroglobulin antibodies, which means your immune system is slowly destroying your thyroid and your hair loss is part of an autoimmune process.

With an MTHFR variant, hair thinning may be accompanied by subtle immune activation (fatigue, low-grade inflammation, occasional swollen lymph nodes). You might respond well to thyroid hormone replacement but never fully recover because the underlying autoimmune process continues unchecked. Your body struggles to clear thyroid hormones efficiently and recycle them, so you may have erratic energy and mood.

VDR is the receptor through which vitamin D exerts its immune-modulating effects. Vitamin D is actually a hormone, and your cells can only respond to it if they have functional VDR receptors. Since roughly 50-70% of thyroid disease is autoimmune in origin, VDR function directly determines whether your immune system attacks your thyroid or tolerates it.

VDR variants (multiple SNPs including FokI, BsmI, ApaI, TaqI) are extremely common and alter the efficiency of vitamin D signaling. People with certain VDR variants have reduced sensitivity to vitamin D, meaning they need higher circulating levels to achieve the same immune-regulatory effect, and they face substantially higher thyroid autoimmunity and hair loss risk. The mechanism: without strong VDR signaling, regulatory T cells cannot suppress the attack on thyroid tissue, so anti-TPO and anti-thyroglobulin antibodies climb unchecked.

With a VDR variant, hair loss often correlates with vitamin D insufficiency even if your lab levels look ‘adequate’ by standard ranges. You might get thyroid antibodies under control only when vitamin D is pushed to the upper healthy range (50-80 ng/mL). You may also experience worse hair thinning in winter or in climates with less sun exposure.

HLA-DQ2 is an antigen presented by immune cells that marks you as genetically susceptible to celiac disease and also associated with increased thyroid autoimmunity risk. If you carry HLA-DQ2, your immune system can be triggered by gluten peptides and mount an attack that cross-reacts with thyroid tissue (a phenomenon called molecular mimicry). Hair loss in HLA-DQ2 carriers often correlates with celiac-driven inflammation and micronutrient malabsorption.

HLA-DQ2 is carried by roughly 30-40% of the general population but is present in over 90% of celiac disease cases and strongly associated with Hashimoto’s thyroiditis. If you carry HLA-DQ2 and have thyroid autoimmunity, removing gluten is not optional; it is a primary lever for controlling thyroid antibodies and halting hair loss. Even without classic celiac symptoms (diarrhea, bloating), gluten triggers low-grade intestinal inflammation in HLA-DQ2 carriers, increases intestinal permeability, and magnifies the cross-reactive attack on thyroid tissue.

With HLA-DQ2 and thyroid autoimmunity, your hair loss may be driven not by insufficient thyroid hormone but by active immune destruction of the thyroid gland. Standard levothyroxine replacement alone cannot stop this process. Hair may not regrow until you eliminate gluten and allow your immune system to reset.